SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-011022
Filing Date
2020-06-11
Accepted
2020-06-11 17:27:16
Documents
18
Period of Report
2020-06-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 185385
2 ex3-1.htm EX-3.1 201646
3 ex3-2.htm EX-3.2 202573
4 ex3-3.htm EX-3.3 100254
5 ex3-4.htm EX-3.4 100413
6 ex3-5.htm EX-3.5 1708
7 ex4-1.htm EX-4.1 100413
8 ex4-2.htm EX-4.2 71228
9 ex10-1.htm EX-10.1 80238
10 ex10-2.htm EX-10.2 73511
11 ex10-3.htm EX-10.3 55240
12 ex10-4.htm EX-10.4 77027
13 ex10-5.htm EX-10.5 49299
14 ex10-6.htm EX-10.6 61813
15 ex99-1.htm EX-99.1 14191
16 ex99-2.htm EX-99.2 17668
17 ex3-5_001.jpg GRAPHIC 492547
18 ex3-5_002.jpg GRAPHIC 276134
  Complete submission text file 0001493152-20-011022.txt   2453265
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52218 | Film No.: 20958051
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences